Triple-S Management Corporation (NYSE: GTS) Stock Competitors & Peer Comparison
See GTS's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Plans Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for GTS and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| GTS | $35.99 | +1.04% | 0 | 10.41 | $3.46 | N/A |
| UNH | $407.08 | +0.77% | 369.7B | 24.91 | $16.34 | +2.18% |
| CVS | $95.70 | -0.54% | 122.1B | 12.20 | $7.84 | +2.78% |
| ANTM | $482.58 | +2.71% | 114.6B | 18.99 | $25.41 | +1.42% |
| ELV | $394.20 | +0.76% | 85.5B | 13.41 | $29.39 | +1.74% |
| CI | $282.49 | +2.63% | 74.6B | 9.14 | $30.90 | +2.18% |
| HUM | $385.00 | +4.84% | 46.2B | 24.28 | $15.86 | +0.92% |
| CNC | $65.77 | +2.45% | 32.5B | 26.11 | $2.52 | N/A |
| MOH | $196.45 | +2.38% | 10.3B | 28.39 | $6.92 | N/A |
| OSCR | $27.90 | +5.12% | 7.2B | 19.93 | $1.40 | N/A |
Stock Comparison
UnitedHealth Group Incorporated (NYSE: UNH)
GTS vs UNH Comparison August 2026
Triple-S Management Corporation (NYSE: GTS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTS stands at 0. In comparison, UNH has a market cap of 369.7B. Regarding current trading prices, GTS is priced at $35.99 on the NYSE, while UNH trades at $407.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTS currently has a P/E ratio of 10.41, whereas UNH's P/E ratio is 24.91. In terms of profitability, GTS's ROE is +0.07%, compared to UNH's ROE of +0.14%. Regarding short-term risk, GTS is less volatile compared to UNH. This indicates lower risk in terms of short-term price fluctuations for GTS.Check UNH's competition here
CVS Health Corp. (NYSE: CVS)
GTS vs CVS Comparison August 2026
Triple-S Management Corporation (NYSE: GTS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTS stands at 0. In comparison, CVS has a market cap of 122.1B. Regarding current trading prices, GTS is priced at $35.99 on the NYSE, while CVS trades at $95.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTS currently has a P/E ratio of 10.41, whereas CVS's P/E ratio is 12.20. In terms of profitability, GTS's ROE is +0.07%, compared to CVS's ROE of +0.06%. Regarding short-term risk, GTS is less volatile compared to CVS. This indicates lower risk in terms of short-term price fluctuations for GTS.Check CVS's competition here
Elevance Health Inc. (NYSE: ANTM)
GTS vs ANTM Comparison August 2026
Triple-S Management Corporation (NYSE: GTS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTS stands at 0. In comparison, ANTM has a market cap of 114.6B. Regarding current trading prices, GTS is priced at $35.99 on the NYSE, while ANTM trades at $482.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTS currently has a P/E ratio of 10.41, whereas ANTM's P/E ratio is 18.99. In terms of profitability, GTS's ROE is +0.07%, compared to ANTM's ROE of +0.11%. Regarding short-term risk, GTS is less volatile compared to ANTM. This indicates lower risk in terms of short-term price fluctuations for GTS.Check ANTM's competition here
Elevance Health Inc. (NYSE: ELV)
GTS vs ELV Comparison August 2026
Triple-S Management Corporation (NYSE: GTS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTS stands at 0. In comparison, ELV has a market cap of 85.5B. Regarding current trading prices, GTS is priced at $35.99 on the NYSE, while ELV trades at $394.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTS currently has a P/E ratio of 10.41, whereas ELV's P/E ratio is 13.41. In terms of profitability, GTS's ROE is +0.07%, compared to ELV's ROE of +0.11%. Regarding short-term risk, GTS is less volatile compared to ELV. This indicates lower risk in terms of short-term price fluctuations for GTS.Check ELV's competition here
Cigna Corporation (NYSE: CI)
GTS vs CI Comparison August 2026
Triple-S Management Corporation (NYSE: GTS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTS stands at 0. In comparison, CI has a market cap of 74.6B. Regarding current trading prices, GTS is priced at $35.99 on the NYSE, while CI trades at $282.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTS currently has a P/E ratio of 10.41, whereas CI's P/E ratio is 9.14. In terms of profitability, GTS's ROE is +0.07%, compared to CI's ROE of +0.15%. Regarding short-term risk, GTS is less volatile compared to CI. This indicates lower risk in terms of short-term price fluctuations for GTS.Check CI's competition here
Humana Inc. (NYSE: HUM)
GTS vs HUM Comparison August 2026
Triple-S Management Corporation (NYSE: GTS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTS stands at 0. In comparison, HUM has a market cap of 46.2B. Regarding current trading prices, GTS is priced at $35.99 on the NYSE, while HUM trades at $385.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTS currently has a P/E ratio of 10.41, whereas HUM's P/E ratio is 24.28. In terms of profitability, GTS's ROE is +0.07%, compared to HUM's ROE of +0.07%. Regarding short-term risk, GTS is less volatile compared to HUM. This indicates lower risk in terms of short-term price fluctuations for GTS.Check HUM's competition here
Centene Corp. (NYSE: CNC)
GTS vs CNC Comparison August 2026
Triple-S Management Corporation (NYSE: GTS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTS stands at 0. In comparison, CNC has a market cap of 32.5B. Regarding current trading prices, GTS is priced at $35.99 on the NYSE, while CNC trades at $65.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTS currently has a P/E ratio of 10.41, whereas CNC's P/E ratio is 26.11. In terms of profitability, GTS's ROE is +0.07%, compared to CNC's ROE of -0.24%. Regarding short-term risk, GTS is less volatile compared to CNC. This indicates lower risk in terms of short-term price fluctuations for GTS.Check CNC's competition here
Molina Healthcare, Inc. (NYSE: MOH)
GTS vs MOH Comparison August 2026
Triple-S Management Corporation (NYSE: GTS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTS stands at 0. In comparison, MOH has a market cap of 10.3B. Regarding current trading prices, GTS is priced at $35.99 on the NYSE, while MOH trades at $196.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTS currently has a P/E ratio of 10.41, whereas MOH's P/E ratio is 28.39. In terms of profitability, GTS's ROE is +0.07%, compared to MOH's ROE of -0.00%. Regarding short-term risk, GTS is less volatile compared to MOH. This indicates lower risk in terms of short-term price fluctuations for GTS.Check MOH's competition here
Oscar Health, Inc. (NYSE: OSCR)
GTS vs OSCR Comparison August 2026
Triple-S Management Corporation (NYSE: GTS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTS stands at 0. In comparison, OSCR has a market cap of 7.2B. Regarding current trading prices, GTS is priced at $35.99 on the NYSE, while OSCR trades at $27.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTS currently has a P/E ratio of 10.41, whereas OSCR's P/E ratio is 19.93. In terms of profitability, GTS's ROE is +0.07%, compared to OSCR's ROE of +0.39%. Regarding short-term risk, GTS is less volatile compared to OSCR. This indicates lower risk in terms of short-term price fluctuations for GTS.Check OSCR's competition here
Alignment Healthcare, Inc. (NASDAQ: ALHC)
GTS vs ALHC Comparison August 2026
Triple-S Management Corporation (NYSE: GTS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTS stands at 0. In comparison, ALHC has a market cap of 3B. Regarding current trading prices, GTS is priced at $35.99 on the NYSE, while ALHC trades at $14.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTS currently has a P/E ratio of 10.41, whereas ALHC's P/E ratio is 159.67. In terms of profitability, GTS's ROE is +0.07%, compared to ALHC's ROE of +0.20%. Regarding short-term risk, GTS is less volatile compared to ALHC. This indicates lower risk in terms of short-term price fluctuations for GTS.Check ALHC's competition here
Clover Health Investments, Corp. (NASDAQ: CLOV)
GTS vs CLOV Comparison August 2026
Triple-S Management Corporation (NYSE: GTS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTS stands at 0. In comparison, CLOV has a market cap of 2.5B. Regarding current trading prices, GTS is priced at $35.99 on the NYSE, while CLOV trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTS currently has a P/E ratio of 10.41, whereas CLOV's P/E ratio is 111.63. In terms of profitability, GTS's ROE is +0.07%, compared to CLOV's ROE of -0.05%. Regarding short-term risk, GTS is less volatile compared to CLOV. This indicates lower risk in terms of short-term price fluctuations for GTS.Check CLOV's competition here
Bright Health Group, Inc. (NYSE: BHG)
GTS vs BHG Comparison August 2026
Triple-S Management Corporation (NYSE: GTS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTS stands at 0. In comparison, BHG has a market cap of 130.5M. Regarding current trading prices, GTS is priced at $35.99 on the NYSE, while BHG trades at $16.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTS currently has a P/E ratio of 10.41, whereas BHG's P/E ratio is -0.12. In terms of profitability, GTS's ROE is +0.07%, compared to BHG's ROE of +0.04%. Regarding short-term risk, GTS is less volatile compared to BHG. This indicates lower risk in terms of short-term price fluctuations for GTS.Check BHG's competition here
Caring Brands, Inc. (NASDAQ: CABR)
GTS vs CABR Comparison August 2026
Triple-S Management Corporation (NYSE: GTS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTS stands at 0. In comparison, CABR has a market cap of 12.1M. Regarding current trading prices, GTS is priced at $35.99 on the NYSE, while CABR trades at $1.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTS currently has a P/E ratio of 10.41, whereas CABR's P/E ratio is -2.38. In terms of profitability, GTS's ROE is +0.07%, compared to CABR's ROE of -3.28%. Regarding short-term risk, GTS is less volatile compared to CABR. This indicates lower risk in terms of short-term price fluctuations for GTS.Check CABR's competition here
Magellan Health, Inc. (NASDAQ: MGLN)
GTS vs MGLN Comparison August 2026
Triple-S Management Corporation (NYSE: GTS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTS stands at 0. In comparison, MGLN has a market cap of 0. Regarding current trading prices, GTS is priced at $35.99 on the NYSE, while MGLN trades at $94.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTS currently has a P/E ratio of 10.41, whereas MGLN's P/E ratio is 8.49. In terms of profitability, GTS's ROE is +0.07%, compared to MGLN's ROE of +0.00%. Regarding short-term risk, GTS is more volatile compared to MGLN. This indicates higher risk in terms of short-term price fluctuations for GTS.Check MGLN's competition here
Aetna Inc. (NYSE: AET)
GTS vs AET Comparison August 2026
Triple-S Management Corporation (NYSE: GTS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTS stands at 0. In comparison, AET has a market cap of 0. Regarding current trading prices, GTS is priced at $35.99 on the NYSE, while AET trades at $106.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTS currently has a P/E ratio of 10.41, whereas AET's P/E ratio is 9.57. In terms of profitability, GTS's ROE is +0.07%, compared to AET's ROE of +0.11%. Regarding short-term risk, GTS is more volatile compared to AET. This indicates higher risk in terms of short-term price fluctuations for GTS.Check AET's competition here
Universal American Corporation (NYSE: UAM)
GTS vs UAM Comparison August 2026
Triple-S Management Corporation (NYSE: GTS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GTS stands at 0. In comparison, UAM has a market cap of 0. Regarding current trading prices, GTS is priced at $35.99 on the NYSE, while UAM trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GTS currently has a P/E ratio of 10.41, whereas UAM's P/E ratio is 1.01. In terms of profitability, GTS's ROE is +0.07%, compared to UAM's ROE of +0.17%. Regarding short-term risk, GTS is more volatile compared to UAM. This indicates higher risk in terms of short-term price fluctuations for GTS.Check UAM's competition here